BunnyRayRay
預約了直播
[概要]
隨著自 2024 年初以來的全球市場轉型,積極投資者如何在投資策略中捕捉這些關鍵轉變和演變?透過我們年中基金系列的最後一場直播網路研討會,了解像您這樣的投資者如何潛在利用收入策略,與我們來自 PIMCO 和新加坡 Moomoo 的專家一起解決全球變化。加入我們,您可能會獲得 Qu...
隨著自 2024 年初以來的全球市場轉型,積極投資者如何在投資策略中捕捉這些關鍵轉變和演變?透過我們年中基金系列的最後一場直播網路研討會,了解像您這樣的投資者如何潛在利用收入策略,與我們來自 PIMCO 和新加坡 Moomoo 的專家一起解決全球變化。加入我們,您可能會獲得 Qu...
已翻譯
18
BunnyRayRay
讚了
$吉利德科學(GILD.US$ $Myovant Sciences(MYOV.US$
$迪士尼(DIS.US$ $Myovant Sciences(MYOV.US$
3 reasons to consider MYOV after taking profit
1) great fundamentals - great leaps in price to sales ratio (value) and also enterprise value to EBITA (growth) Q to Q
a) 2 approved life saving/changing blockbusters and more pending. Not going into technical but manydoctors and client attested to the benefits and the increasing scripts speaks of itself
b) strong financials - huge cash runway of $6b+ cash for a $1.4b market capital company with incoming streams of income from tiered payments and commercialising sales of 2 great products
c) Experienced Pfizer commercialising the above drugs.. acknowledging the value with 4.2b tiered payment.. Pfizer taking this on also speaks volume andthe confidence in the 4.2b price for 50%
2) Buyout Target for Sumi who is facing a patent cliff and can fully own last of the “vant” company or secondary contender PFizer who is flooded with cash and looking to buy. Lots of M&A happening in this space.
3)Fantastic Value and looking at a reversal trend. Cyclical move into biomed.. great oppty and timing for the buyout before price become higher…and short squeeze due to manupulation of the bullies in a Low float enviroment… through observation of the capital flow trends and also price movements
$迪士尼(DIS.US$ $Myovant Sciences(MYOV.US$
3 reasons to consider MYOV after taking profit
1) great fundamentals - great leaps in price to sales ratio (value) and also enterprise value to EBITA (growth) Q to Q
a) 2 approved life saving/changing blockbusters and more pending. Not going into technical but manydoctors and client attested to the benefits and the increasing scripts speaks of itself
b) strong financials - huge cash runway of $6b+ cash for a $1.4b market capital company with incoming streams of income from tiered payments and commercialising sales of 2 great products
c) Experienced Pfizer commercialising the above drugs.. acknowledging the value with 4.2b tiered payment.. Pfizer taking this on also speaks volume andthe confidence in the 4.2b price for 50%
2) Buyout Target for Sumi who is facing a patent cliff and can fully own last of the “vant” company or secondary contender PFizer who is flooded with cash and looking to buy. Lots of M&A happening in this space.
3)Fantastic Value and looking at a reversal trend. Cyclical move into biomed.. great oppty and timing for the buyout before price become higher…and short squeeze due to manupulation of the bullies in a Low float enviroment… through observation of the capital flow trends and also price movements
7
BunnyRayRay
讚了
1
BunnyRayRay
讚了
$奈飛(NFLX.US$ Netflix 週二宣布在印度大幅降價高達 60%,旨在恢復市場份額 $亞馬遜(AMZN.US$ 和 $迪士尼(DIS.US$。該公司週二在一份聲明中表示,它已經降低了所有四層套餐的價格,其中最大的降價是從 499 盧比(每月 199 盧比)的入門級套餐。新價格將使印度觀眾更容易訪問流媒體服務。
已翻譯
12
BunnyRayRay
讚了
市場快照:
對於交易所買賣基金交易者而言,股市的快速反彈是一個好消息,他們在高點技術投注下跌破紀錄的 1.5 億美元。
搭配 $納斯達克100指數(.NDX.US$ 週二和溫德日激增,這似乎對投資者來說是證明 $3倍做多納指ETF-ProShares(TQQQ.US$ 在星期五戰中大量。
當天的報價:
今天有人坐在陰涼處,因為很久以前有人種了一棵樹- 瓦雷姆·巴菲特
$納斯達克(NDAQ.US$ $標普500指數(.SPX.US$ $道瓊斯指數(.DJI.US$
對於交易所買賣基金交易者而言,股市的快速反彈是一個好消息,他們在高點技術投注下跌破紀錄的 1.5 億美元。
搭配 $納斯達克100指數(.NDX.US$ 週二和溫德日激增,這似乎對投資者來說是證明 $3倍做多納指ETF-ProShares(TQQQ.US$ 在星期五戰中大量。
當天的報價:
今天有人坐在陰涼處,因為很久以前有人種了一棵樹- 瓦雷姆·巴菲特
$納斯達克(NDAQ.US$ $標普500指數(.SPX.US$ $道瓊斯指數(.DJI.US$
已翻譯
28
1